ABU DHABI / AD MEDIA OFFICE
In line with the efforts of the Department of Health – Abu Dhabi (DoH) to further the emirate’s position as a global healthcare destination and leader in organ donation and transplantation, M42, a merger of Mubadala Health and G42 Healthcare, has formed a strategic partnership with Royal Medical Services (RMS) of Bahrain, to advance healthcare accessibility and quality across borders. The landmark partnership signifies a pivotal moment in reshaping the future of health in the region.
As part of the strategic alliance, M42 formally signed its first memorandum of understanding (MoU) with Royal Medical Services (RMS) to provide world-class heart and lung transplant surgical procedures for patients in Bahrain. This partnership, part of the National Program for Organ and Tissue Donation and Transplantation “Hayat,” reflects Abu Dhabi’s leading capabilities in organ transplantation, supported by advanced infrastructure, and world-class healthcare professionals and facilities.
The MoU was formally signed by His Excellency Brig Gen (Dr) Shaikh Fahad bin Khalifa bin Salman Al Khalifa, Commander of Royal Medical Services, and Hasan Jasem Al Nowais, M42 Managing Director and Group Chief Executive Officer and Chairman of Cleveland Clinic Abu Dhabi, during a ceremony held at the M42 booth at the Arab Health Exhibition and Conferences.
Under this agreement, Cleveland Clinic Abu Dhabi, part of the M42 group, will play a vital role in providing specialised services. The multi-organ transplant centre at Cleveland Clinic Abu Dhabi offers cutting-edge transplantation services with multidisciplinary care to patients from across the region and beyond.
As the UAE’s first and only multi-organ transplant facility, the hospital has successfully completed over 774 transplants since its inception in 2017, with 241 performed in 2024 alone. Additionally, Cleveland Clinic Abu Dhabi has earned recognition from the Department of Health – Abu Dhabi (DoH) as a Centre of Excellence for Adult Cardiac Surgery.
By leveraging the global expertise and technology advancements of Cleveland Clinic Abu Dhabi in performing heart and lung transplant surgeries and the extensive resources of Royal Medical Services, patients in Bahrain will now have access to complex care pathways, from pre-operative assessments to post-operative follow-ups.
His Excellency Brig Gen (Dr) Shaikh Fahad bin Khalifa bin Salman Al Khalifa, Commander of Royal Medical Services, said: “This partnership signifies a remarkable synergy between the Abu Dhabi Government and Bahrain, as we work together to enhance healthcare accessibility and outcomes for our communities.”
“I am proud to form this strategic alliance with M42, a partnership that embodies our shared commitment to medical excellence and innovation. I am confident that M42’s collective expertise, combined with our resources, will benefit countless people in need, enhancing healthcare outcomes and accessibility across the region.”
Hasan Jasem Al Nowais, M42 Managing Director and Group Chief Executive Officer, said: “M42 is forming strategic collaborations to reshape the future of health and drive impactful global change. In partnering with Bahrain’s Royal Medical Services, we are together serving the people of the country with life-saving transplant procedures and personalised care, establishing a new benchmark for healthcare delivery in the region overall. This is an important development in driving healthcare access and awareness, enhancing education and service delivery, and improving health equity across the region.”
The collaboration between M42 and RMS reflects a comprehensive approach to medical advancement. In the coming months and years, the strategic alliance will see the delivery of the highest standard of medical education and knowledge exchange; fellowship programmes for clinical staff; provision of advanced laboratory diagnostic services including genomics; joint research and academic programmes focused on advancing clinical care in complex medical fields; and the development and deployment of new technologies to enhance care delivery.